GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹2,194 Cr | ₹991 Cr | ₹4,348 Cr | ₹3,670 Cr | ₹4,687 Cr |
What is the latest Total Debt ratio of GLENMARK PHARMACEUTICALS ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹2,194 Cr |
| Mar2024 | ₹991 Cr |
| Mar2023 | ₹4,348 Cr |
| Mar2022 | ₹3,670 Cr |
| Mar2021 | ₹4,687 Cr |
How is Total Debt of GLENMARK PHARMACEUTICALS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,194 Cr | 121.50 | |
| Mar2024 | ₹991 Cr | -77.22 | |
| Mar2023 | ₹4,348 Cr | 18.46 | |
| Mar2022 | ₹3,670 Cr | -21.70 | |
| Mar2021 | ₹4,687 Cr | - | |
Compare Total Debt of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹58,903.6 Cr | 0.3% | 7.5% | 46.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,596.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹98,767.6 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 0.3% |
7.5% |
46.6% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses